Looking for a Proair Hfa attorney in Washington, DC? Get in touch with one of our Proair Hfa attorneys in Washington, DC now.
Home : FDA Drug Database : Proair Hfa : News Articles
Proair Hfa - News Articles
-
??? ????? ?? ??? ??? ???? ???? ?? 54% ???? ????? ?- HFA ????? ??? ??? ?? 56% ?????? ????. ???? ?????? ?????, ????? ?????? Barr, ???? ?????? ?? 77 ?????? ... -
May 6, 2008
Pharma Times (subscription), UK -
Israel's Teva Pharmaceutical Industries has posted another strong set of financials for the first-quarter, despite net income falling 57% to $147 million, or $0.18 per share. The earnings decline was due to a $382 million charge the Petah Tikvah-based firm ... -
May 6, 2008
Globes, Israel -
Analysts at investment houses have been responding to today's first quarter results from Teva Pharmaceutical Industries Ltd.'s (Nasdaq: TEVA; TASE: TEVA), ... -
Tuesday, May 06, 2008
Market Intelligence Center, VA -
Teva Pharmaceutical Industries Ltd. (TEVA) opened at 46.50. So far today, the stock has hit a low of 46.10 and a high of 46.70. TEVA is now trading at 46.08 , down 1.24 (-2.67%). The stock hit its 52 week high of 50.00 in February and set its 52 week ... -
Tuesday, May 06, 2008
Research Oracle, UK -
Teva Pharmaceutical Industries Limited’s (Teva) results were better than our expectations in 1Q 08. The strong performance was driven by improved performance of its flagship product, Copaxone and higher generic sales. Considering the better-than-expected results we may revise our estimates ... -
May 5, 2008
CNNMoney.com -
NEW YORK (Associated Press) - A Goldman Sachs analyst said Monday he expects Teva Pharmaceutical to update investors on its pending patent challenges when the Israeli generic drugmaker reports first-quarter earnings on Tuesday. Following last week's Paragraph IV conference in New York, ... -
May 6, 2008
Reuters -
TEL AVIV (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O: Quote, Profile, Research) (TEVA.TA: Quote, Profile, Research), the world's largest generic ...
-
May 6, 2008
BusinessWeek -
Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Tuesday its first-quarter profit fell on a hefty charge related to its purchase of CoGenesys, but adjusted earnings topped Wall Street expectations. Net income fell ... -
May 6, 2008
Reuters -
TEL AVIV, May 6 (Reuters) - Israel's Teva Pharmaceutical Industries (TEVA.O: Quote, Profile, Research) (TEVA.TA: Quote, Profile, Research), the world's biggest maker of generic drugs, said on Tuesday it was not making any changes to its earnings ... -
Tuesday, May 06, 2008
Forbes, NY -
By Tova Cohen TEL AVIV, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd (nasdaq: TEVA - news - people ), the world's largest generic drugmaker, ... -
Tuesday, May 06, 2008
CNNMoney.com -
NEW YORK -(Dow Jones)- Teva Pharmaceutical Industries Inc.'s (TEVA) first- quarter net income fell 57%, reflecting an acquisition charge, as sales of multiple sclerosis treatment Copaxone rose 35%, at a pace the company doesn't expect to continue. ... -
Tuesday, May 06, 2008
Houston Chronicle, United States -
© 2008 AP NEW YORK — Analysts said Teva Pharmaceutical's overall first-quarter results were solid, but said a sticking point for some on Wall Street was the large role favorable currency exchange rates played in boosting revenue. American Depositary ... -
Tuesday, May 06, 2008
MarketWatch -
By Robert Daniel, MarketWatch TEL AVIV (MarketWatch) -- Teva Pharmaceutical Industries Inc. reported first-quarter net income fell 57% on Tuesday, reflecting a charge tied to an acquisition. ... -
Tuesday, May 06, 2008
Forbes, NY -
In spite of a blow to Teva Pharmaceuticals's sales of Pfizer's Celebrex, the generic manufacturer continues to rule as the leading seller of generics. As health-care costs continue to rise in the United States and large pharmaceutical companies watch their pipelines ...
Looking for a Proair Hfa attorney in Washington, DC? Get in touch with one of our Proair Hfa attorneys in Washington, DC now.
